1,007 reports of this reaction
1.4% of all CICLESONIDE reports
#16 most reported adverse reaction
FULL BLOOD COUNT ABNORMAL is the #16 most commonly reported adverse reaction for CICLESONIDE, manufactured by Covis Pharma US, Inc. There are 1,007 FDA adverse event reports linking CICLESONIDE to FULL BLOOD COUNT ABNORMAL. This represents approximately 1.4% of all 74,022 adverse event reports for this drug.
Patients taking CICLESONIDE who experience full blood count abnormal should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FULL BLOOD COUNT ABNORMAL is a less commonly reported adverse event for CICLESONIDE, but still significant enough to appear in the safety profile.
In addition to full blood count abnormal, the following adverse reactions have been reported for CICLESONIDE:
The following drugs have also been linked to full blood count abnormal in FDA adverse event reports:
FULL BLOOD COUNT ABNORMAL has been reported as an adverse event in 1,007 FDA reports for CICLESONIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FULL BLOOD COUNT ABNORMAL accounts for approximately 1.4% of all adverse event reports for CICLESONIDE, making it a notable side effect.
If you experience full blood count abnormal while taking CICLESONIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.